This Article Full Text Full Text (PDF) Supplemental Data Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Freson, K. Articles by Van Geet, C. Search for Related Content PubMed PubMed Citation Articles by Freson, K. Articles by Van Geet, C. Related Collections Pediatric Endocrinology Thyroid Calcium and Bone Metabolism Cardiovascular Endocrinology Obesity

Compound Heterozygous Mutations in the GNAS Gene of a Boy with Morbid Obesity, Thyroid-Stimulating Hormone Resistance, Pseudohypoparathyroidism, and a Prothrombotic State

Center of Molecular and Vascular Biology (K.F., B.I., C.T., C.W., C.V.G.) and Department of Pediatrics (J.J., M.V.H., F.d.Z., C.V.G.), University Hospital Gasthuisberg, University of Leuven, B-3000 Leuven, Belgium

Address all correspondence and requests for reprints to: Kathleen Freson, Center for Molecular and Vascular Biology, University of Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail: Kathleen.freson{at}med.kuleuven.be.

Context: Pseudohypoparathyroidism type Ia and pseudopseudohypoparathyroidism are characterized by Albright’s hereditary osteodystrophy (AHO), respectively, with and without hormone resistance. Both clinical conditions result from decreased expression or function of the -subunit of the stimulatory G protein (Gs) of adenylyl cyclase due to heterozygous inactivating mutations in GNAS. Homozygous GNAS defects have not been described.

Objective: A genetic and functional GNAS study was undertaken in a boy with morbid obesity (body mass index Z-score of 5 at the age of 3 yr, with a body fat fraction of 40%, which is more than twice normal), TSH resistance, pseudohypoparathyroidism, and a prothrombotic state.

Results: The boy was found to be a first case with a compound heterozygous GNAS defect: a de novo R231C mutation on the paternal allele and on the other allele a maternally inherited unique combination of three C to T nucleotide substitutions in exon 7 (I185I), intron 7 (IVS7 + 31), and exon 13 (N371N) leading to aberrant splicing of GNAS. Platelets of this boy displayed a pronounced Gs hypofunction and were spontaneously hyperreactive resulting in a prothrombotic state due to extremely low cAMP levels.

Conclusion: This report expands the human GNAS genotype-phenotype spectrum to include compound heterozygosity and a prothrombotic state.